Enquiry/Quote
Clindamycin Phosphate Injection bulk supplier for pharma manufacturers

Clindamycin Phosphate Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 150mg/ml

Reference Brands: Dalacin C (EU), Cleocin Phosphate (USA)

Category: Antibiotics

Clindamycin injection is used to treat certain types of bacterial infections, including infections of the lungs, skin, blood, bones, joints, female reproductive organs, and internal organs. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria. Clindamycin Phosphate Injection is available in Injection and strengths such as 150mg/ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Clindamycin Phosphate Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Clindamycin Phosphate Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Clindamycin is a lincosamide class antimicrobial agent widely used for the treatment of a variety of bacterial infections caused by susceptible organisms. It is effective against many anaerobic bacteria and certain gram-positive bacteria, making it a valuable therapeutic option in clinical practice. Clindamycin is commonly prescribed for conditions such as septicemia, gynecological infections, lower respiratory tract infections, skin and soft tissue infections, bone and joint infections, and intra-abdominal infections.

The medication works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of bacteria. Due to its strong tissue penetration and broad antimicrobial activity, clindamycin plays an important role in the management of both mild and severe infections. It is available in multiple dosage forms including capsules, injections, topical formulations, and oral suspensions, allowing flexible treatment options depending on the severity and type of infection.

Understanding the therapeutic applications of clindamycin also involves awareness of its mechanism of action, contraindications, potential drug interactions, and possible adverse effects. With appropriate clinical use, clindamycin remains an important antibiotic in modern medicine, helping healthcare professionals effectively treat a wide range of infectious diseases and improve patient outcomes.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Clindamycin Injection is used to treat serious bacterial infections caused by susceptible bacteria, particularly anaerobic bacteria and certain gram-positive organisms. It is commonly prescribed for respiratory tract infections, skin and soft tissue infections, bone and joint infections, intra-abdominal infections, septicemia, and gynecological infections. The injectable form is typically used in hospital settings when oral therapy is not suitable or when rapid therapeutic action is required.

Clindamycin Injection contains the active pharmaceutical ingredient clindamycin phosphate, which is the injectable form of the antibiotic clindamycin. It belongs to the lincosamide class of antibiotics and works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of bacteria.

Clindamycin Injection is marketed under several trade names worldwide including Cleocin Injection, Dalacin C Injection, and other generic clindamycin injectable brands depending on the manufacturer and region.

One of the well-known brands, Cleocin Injection, was originally developed and marketed by Pfizer. Today, clindamycin injection is manufactured globally by several pharmaceutical companies including Teva Pharmaceutical Industries, Sandoz, and Viatris along with other generic manufacturers.

The generic name of Clindamycin Injection is clindamycin phosphate.

Common brand names of Clindamycin Injection include Cleocin Injection and Dalacin C Injection.

Clindamycin Injection is manufactured in several countries including the United States, India, China, and multiple European countries by different pharmaceutical manufacturers supplying both branded and generic injectable formulations for global markets.

Yes, Clindamycin Phosphate Injection is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Clindamycin Phosphate Injection is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Rifaximin

Strength:
100 mg/5 mL, 200 mg, 550 mg

Form: Tablet / Oral Suspension

Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)

View Details
Ceftaroline

Strength:
600 mg

Form: Injection

Reference Brands: Teflaro (USA), Zinforo (EU)

View Details
Secnidazole

Strength:
2 g

Form: Oral granules/ tablets

Reference Brands: Solosec (USA)

View Details
Omaveloxolone

Strength:
150 mg

Form: Tablets

Reference Brands: Skyclarys (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.